Share

May 07, 2019; 92 (19) Article

Lipid levels and the risk of hemorrhagic stroke among women

Pamela M. Rist, Julie E. Buring, Paul M Ridker, Carlos S. Kase, Tobias Kurth, Kathryn M. Rexrode
First published April 10, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007454
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
3395

Share

Article Information

vol. 92 no. 19 e2286-e2294
DOI: 
https://doi.org/10.1212/WNL.0000000000007454
PubMed: 
30971484
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received July 25, 2018
  • Accepted in final form January 14, 2019
  • First Published April 10, 2019.

Article Versions

Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Pamela M. Rist, ScD,
    2. Julie E. Buring, ScD,
    3. Paul M Ridker, MD, MPH,
    4. Carlos S. Kase, MD,
    5. Tobias Kurth, MD, ScD* and
    6. Kathryn M. Rexrode, MD, MPH*
  1. Pamela M. Rist, ScD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Charit? ? Universit?tsmedizin Berlin, funding for travel and speaker honoraria

    Editorial Boards:

    1. Stroke, statistical editor, 2016-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHLBI, K01HL128791, Principle investigator, 2016-present NHLBI, R01HL088521, Project director, 2015-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NCMIC Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Julie E. Buring, ScD,
    3. Scientific Advisory Boards:

    1. Husband - Scientific Advisory Board of Pharmavite

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. honorarium from Bayer for presenting Women's Health Study trial results at a symposium at national meeting, 2005

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Research support for pills and/or packaging was provided by Bayer HeathCare and the Natural Source Vitamin E Association for the Women's Health Study.

    Research Support, Government Entities:

    1. NIH grants supporting the Women's Health Study

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Paul M Ridker, MD, MPH,
    4. Scientific Advisory Boards:

    1. 1). Corvidia, BioCivi 2). NHLBI

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1). Novartis, Amgen, Jannsen, Merck - consultant

    Editorial Boards:

    1. 1. Circulation Research, AHA 5 years

    Patents:

    1. 1. Patents related to the use of inflammatory biomarkers in cardiovascular disease held by the Brigham and Women's Hospital and licensed to Seimens.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1). Novartis, Amgen, Jannsen, Merck - consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Novartis, Kowa, Pfizer - unrelated research grants

    Research Support, Government Entities:

    1. NHLBI, NCI - unrelated research grants

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License fee payments, Technology or Inventions:

    1. 1. Patents related to the use of inflammatory biomarkers in cardiovascular disease held by the Brigham and Women's Hospital and licensed to Seimens.

    Royalty Payments, Technology or Inventions:

    1. 1. Patents related to the use of inflammatory biomarkers in cardiovascular disease held by the Brigham and Women's Hospital and licensed to Seimens.

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Carlos S. Kase, MD,
    5. Scientific Advisory Boards:

    1. Boehringer-Ingelheim

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Boehringer-Ingelheim

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Boehringer-Ingelheim

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Tobias Kurth, MD, ScD* and
    6. Scientific Advisory Boards:

    1. (1) Commercial (Lilly, Newsenselab), for providing methodological advice.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Commercial (Novartis, Daiichi Sankyo), for providing a lecture on neuroepidemiology and research methods

    Editorial Boards:

    1. (1) BMJ, for duties as consulting clinical epidemiology editor.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) The Federal Joint Committee Germany, PI of evaluations (ANNOTeM, TNAMSE, SMARTGEM).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Kathryn M. Rexrode, MD, MPH*
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Invited speaker for the International Magnesium conference in Rome 2017 ($500 to cover travel)

    Editorial Boards:

    1. Neuology and JAMA Internal Medicine editorial advisory boards

    Patents:

    1. NONE

    Publishing Royalties:

    1. Editor, Women and Health 2012 (2016 <600$)

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Quincy Bioscience- review of safety reports on over the counter supplements. Prenatal multivitamin review

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHLBI R01- "risk factors for ischemic stroke" ongoing

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Scientific Board for Tegterra/ Inside Tracker. Stock options only with 0$ worth (no stock currently available- not publicly traded- I think unlikely to be ever stock)

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Division of Preventive Medicine, Department of Medicine (P.M. Rist, J.E.B., P.M Ridker), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Neurology (C.S.K.), Emory University, Atlanta, GA; Institute of Public Health (T.K.), Charité–Universitätsmedizin, Berlin, Germany; and Division of Women's Health, Department of Medicine (K.M.R.), Brigham and Women's Hospital, Boston, MA.
  1. Correspondence
    Dr. Rist prist{at}mail.harvard.edu
View Full Text

Article usage

Article usage: April 2019 to January 2020

AbstractFullPdfSource
Apr 20191041402222Highwire
May 2019168022581003Highwire
Jun 201923575939Highwire
Jul 2019325010045Highwire
Aug 201914583917Highwire
Sep 201912761615Highwire
Oct 20198871510Highwire
Nov 20198342816Highwire
Dec 2019828257Highwire
Jan 20209212421Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

More Online

CME Course

Related Articles

Topics Discussed

Alert Me